跳至主要内容
临床试验/NCT01941706
NCT01941706已完成不适用

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Emory University4 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2009年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
130
试验地点
4
主要终点
Changes in Depressive Symptoms

研究概览

简要总结

Project UPLIFT, a home-based treatment for depression in people with epilepsy, was designed to be delivered to groups by telephone or Web. The Project UPLIFT intervention materials were demonstrated to be effective in treating depression among people with epilepsy in Georgia. This project will assess whether the materials are also effective for preventing depression among people with epilepsy, and will extend the project beyond Georgia to Michigan, Texas, and Washington.

详细描述

The study is a pilot test of Project UPLIFT for depression prevention during which the acceptability and estimates of effectiveness of the intervention, presented in the Web and telephone modes, are assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •diagnosis of epilepsy
  • •at least three months post initial diagnosis of epilepsy and either on medication or permission of the physician
  • •symptoms of depression, but absence of moderate-to-severe depression, (8 < CES-D < 27)
  • •21 years of age and older
  • •English speaking
  • •had access to a telephone
  • •mentally stable, as determined by a score of > 26 on the Telephone Mini-Mental Status Exam (T-MMSE)
  • •willing to participate
  • •willing to complete assessments three times

排除标准

  • •no diagnosis of epilepsy
  • •less than 3 months since diagnosis of epilepsy
  • •no depressive symptom (CES-D <8)
  • •severe depression (CES-D > 27)
  • •suicidal ideation
  • •previous participation in Project UPLIFT

研究组 & 干预措施

Project UPLIFT (Treatment)

Experimental

Participants randomly assigned to the Treatment group receive the UPLIFT Intervention immediately after completing the Baseline Assessment. Participants can chose to participate in the Web- or phone-delivery of UPLIFT.

干预措施: Project UPLIFT (Behavioral)

Project UPLIFT (TAU Waitlist Control)

Experimental

Participants randomly assigned to the Treatment-as Usual (TAU) Waitlist Control group will also receive the UPLIFT intervention. However, TAU Waitlist Control participants will begin the Intervention 8 weeks after completing the Baseline Assessment. During the initial 8 weeks, participants in this group will continue whatever treatment they are currently undergoing to prevent or treat mild depressive symptoms. Participants can chose to participate in the Web- or phone-delivery of UPLIFT.

干预措施: Project UPLIFT (Behavioral)

结局指标

主要结局

Changes in Depressive Symptoms

时间窗: Baseline (at 0 week) , Interim (at 8 weeks), Follow-up (at16 weeks)

Changes in depressive symptoms are measured using the modified Beck Depression Inventory (mBDI).

次要结局

  • Changes in Depressive Symptoms(baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks))
  • Changes in seizure severity(Baseline (0 week), Interim (at 8 weeks), Follow-up (at 16 weeks))
  • Changes in Depression and Mindfulness Knowledge and Skills(Baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks))
  • Change in Seizure Activity(Baseline (0 week), Interim (at 8 weeks), Follow-up (at 16 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nancy J Thompson, PhD

Associate Professor, Behavioral Sciences and Health Education

Emory University

研究点 (4)

Loading locations...

相似试验